ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed

April 4, 1980

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

Ethics Commission to Meet In L.A.

September 4, 1981

Curt, Ozols, Brown Leaving NCI; More DCT Staff Changes

June 10, 1988

NCI Advisory Group, Other Cancer Meetings

June 2, 1989

Obey Aide Objects To Criticism Over Earmarking New NCI Positions

August 13, 1976